Turtle Creek Wealth Advisors LLC Grows Position in Intuitive Surgical, Inc. $ISRG

Turtle Creek Wealth Advisors LLC lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 26.8% in the fourth quarter, HoldingsChannel.com reports. The firm owned 9,349 shares of the medical equipment provider’s stock after acquiring an additional 1,975 shares during the quarter. Turtle Creek Wealth Advisors LLC’s holdings in Intuitive Surgical were worth $5,295,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of ISRG. Holos Integrated Wealth LLC purchased a new position in shares of Intuitive Surgical during the 4th quarter worth $25,000. Newbridge Financial Services Group Inc. grew its holdings in shares of Intuitive Surgical by 300.0% during the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 33 shares during the period. Greykasell Wealth Strategies Inc. purchased a new position in shares of Intuitive Surgical during the 3rd quarter worth $27,000. Olistico Wealth LLC purchased a new position in shares of Intuitive Surgical during the 4th quarter worth $28,000. Finally, Caitlin John LLC purchased a new position in shares of Intuitive Surgical during the 3rd quarter worth $30,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

ISRG stock opened at $478.82 on Friday. The firm has a market capitalization of $170.04 billion, a P/E ratio of 58.04, a P/E/G ratio of 3.78 and a beta of 1.68. The business’s 50-day moving average is $477.54 and its two-hundred day moving average is $515.16. Intuitive Surgical, Inc. has a 1 year low of $427.84 and a 1 year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. The company had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.Intuitive Surgical’s revenue for the quarter was up 23.0% compared to the same quarter last year. During the same quarter last year, the company earned $1.81 EPS. On average, analysts expect that Intuitive Surgical, Inc. will post 8.16 EPS for the current year.

Insider Buying and Selling

In other Intuitive Surgical news, SVP Mark Brosius sold 645 shares of the stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $485.01, for a total value of $312,831.45. Following the sale, the senior vice president owned 1,613 shares of the company’s stock, valued at $782,321.13. This trade represents a 28.57% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Patricia L. Wadors sold 220 shares of the stock in a transaction dated Friday, February 27th. The shares were sold at an average price of $499.71, for a total value of $109,936.20. The SEC filing for this sale provides additional information. Insiders sold 32,943 shares of company stock worth $17,279,568 over the last 90 days. 0.60% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the company. Mizuho set a $525.00 price target on Intuitive Surgical and gave the stock a “neutral” rating in a report on Monday, April 13th. JPMorgan Chase & Co. decreased their target price on Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating on the stock in a research note on Wednesday. Jefferies Financial Group decreased their target price on Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating on the stock in a research note on Wednesday. The Goldman Sachs Group increased their target price on Intuitive Surgical from $609.00 to $621.00 and gave the stock a “buy” rating in a research note on Wednesday. Finally, Robert W. Baird increased their target price on Intuitive Surgical from $575.00 to $610.00 and gave the stock an “outperform” rating in a research note on Wednesday. Eighteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $581.91.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Q1 beat and bullish analyst notes reinforce the long?term bull case — TipRanks highlights the quarter as building the bull case after ISRG topped expectations. TipRanks: ISRG Beats Q1 Expectations
• Positive Sentiment: Robert W. Baird raised its price target to $610, signaling confidence in upside after the quarter. Robert W. Baird Raises ISRG Price Target
• Positive Sentiment: BTIG reaffirmed a Buy rating, backing the view that execution and DV5 adoption support growth. BTIG Reaffirms Buy
• Neutral Sentiment: Analysis pieces note a shift to innovation?led, value?based revenue (da Vinci 5 pricing power and recurring sales) — this supports higher margin durability but is a multi?quarter theme rather than an immediate catalyst. Yahoo: Innovation?Led Growth Driving ISRG
• Neutral Sentiment: Company disclosed a contained cyber incident with remediation underway — a risk to monitor but described by management as contained during the earnings call. Yahoo: Growth, AI and Cybersecurity
• Positive Sentiment: Goldman Sachs raised its target and reiterated bullish upside, reflecting confidence in ISRG’s multi?year growth runway. Goldman Sachs Forecasts Strong Price Appreciation
• Negative Sentiment: Jefferies cut its target to $515 and moved to Hold, trimming near?term upside expectations — a contributor to downside pressure for traders focused on valuation. Jefferies Lowers ISRG Price Target
• Negative Sentiment: Leerink and several other firms trimmed targets (e.g., Leerink to $573), reflecting more conservative near?term multiples despite the beat. Leerink Lowers ISRG Price Target
• Negative Sentiment: Raymond James issued a more pessimistic near?term forecast, adding to mixed sell?side guidance that can keep the stock range?bound despite strong fundamentals. Raymond James Issues Pessimistic Forecast

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.